Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity

Autoimmunity Reviews - Tập 15 Số 4 - Trang 379-392 - 2016
Mitesh Dwivedi1, Prasant Kumar1, Naresh C. Laddha2, E. Helen Kemp3
1C. G. Bhakta Institute of Biotechnology, Uka Tarsadia University, Tarsadi, Surat, Gujarat -394350, India
2Department of Molecular Biology, Unipath Specialty Laboratory Ltd., Ahmedabad, Gujarat, India
3Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom

Tóm tắt

Từ khóa


Tài liệu tham khảo

Tilg, 2015, Food, immunity, and the microbiome, Gastroenterology, 148, 1107, 10.1053/j.gastro.2014.12.036

Mazmanian, 2014, Interplay between intestinal microbiota and host immune system, J Bacteriol Virol, 44, 1, 10.4167/jbv.2014.44.1.1

Fuller, 1989, Probiotics in man and animals, J Appl Bacteriol, 66, 365, 10.1111/j.1365-2672.1989.tb05105.x

de Vrese, 2008, Probiotics, prebiotics, and synbiotics, Adv Biochem Eng Biotechnol, 111, 1

Konieczna, 2012, Portrait of an immunoregulatory Bifidobacterium, Gut Microbes, 3, 261, 10.4161/gmic.20358

Geuking, 2014, The interplay between the gut microbiota and the immune system, Gut Microbes, 5, 411, 10.4161/gmic.29330

Konieczna, 2012, Bifidobacterium infantis 35624 administration induces FoxP3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells, Gut, 61, 354, 10.1136/gutjnl-2011-300936

Levings, 2001, Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function, J Exp Med, 193, 1295, 10.1084/jem.193.11.1295

Round, 2009, The gut microbiota shapes intestinal immune responses during health and disease, Nat Rev Immunol, 9, 313, 10.1038/nri2515

Lee, 2010, Has the microbiota played a critical role in the evolution of the adaptive immune system?, Science, 330, 1768, 10.1126/science.1195568

Maloy, 2001, Regulatory T-cells in the control of immune pathology, Nat Immunol, 2, 816, 10.1038/ni0901-816

Klarquist, 2010, Reduced skin homing by functional treg in vitiligo, Pigment Cell Melanoma Res, 23, 276, 10.1111/j.1755-148X.2010.00688.x

Sakaguchi, 2004, Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses, Annu Rev Immunol, 22, 531, 10.1146/annurev.immunol.21.120601.141122

Antiga, 2010, Characterization of regulatory T cells in patients with dermatomyositis, J Autoimmun, 35, 342, 10.1016/j.jaut.2010.07.006

Miyara, 2005, Global natural regulatory T cell depletion in active systemic lupus erythematosus, J Immunol, 175, 8392, 10.4049/jimmunol.175.12.8392

Chi, 2008, Impairment of circulating CD4(+)CD25(+) regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy, J Peripher Nerv Syst, 13, 54, 10.1111/j.1529-8027.2008.00158.x

Dwivedi, 2015, Regulatory T cells in vitiligo: implications for pathogenesis and therapeutics, Autoimmun Rev, 14, 49, 10.1016/j.autrev.2014.10.002

Weiner, 2011, Oral tolerance, Immunol Rev, 241, 241, 10.1111/j.1600-065X.2011.01017.x

Sasaki, 2004, Decidual and peripheral blood CD4+CD25+ regulatory T-cells in early pregnancy subjects and spontaneous abortion cases, Mol Hum Reprod, 10, 347, 10.1093/molehr/gah044

Sugiyama, 2005, Dysfunctional blood and target tissue CD4+ CD25high regulatory T-cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation, J Immunol, 174, 164, 10.4049/jimmunol.174.1.164

Thornton, 2000, Suppressor effector function of CD4+ CD25+ immunoregulatory T-cells is antigen nonspecific, J Immunol, 164, 183, 10.4049/jimmunol.164.1.183

Thornton, 2006, Th17: an effector CD4 T cell lineage with regulatory T cell ties, Immunity, 24, 677, 10.1016/j.immuni.2006.06.002

Cortés, 2014, Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression, J Autoimmun, 55, 51, 10.1016/j.jaut.2014.05.007

Tran, 2009, Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures, Blood, 113, 5125, 10.1182/blood-2009-01-199950

Kleinewietfeld, 2009, CD49d provides access to "untouched" human Foxp3+ treg free of contaminating effector cells, Blood, 113, 827, 10.1182/blood-2008-04-150524

Kornete, 2011, Critical co-stimulatory pathways in the stability of Foxp3+ treg cell homeostasis in type I diabetes, Autoimmun Rev, 11, 104, 10.1016/j.autrev.2011.08.007

Xu, 2012, Targeting IRF4 in autoimmune diseases, Autoimmun Rev, 11, 918, 10.1016/j.autrev.2012.08.011

Miyara, 2009, Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor, Immunity, 30, 899, 10.1016/j.immuni.2009.03.019

Huang, 2004, Role of LAG-3 in regulatory T cells, Immunity, 21, 503, 10.1016/j.immuni.2004.08.010

Seddiki, 2006, Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells, J Exp Med, 203, 1693, 10.1084/jem.20060468

Ronchetti, 2015, Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells, J Immunol Res, 2015, 171520, 10.1155/2015/171520

Petrillo, 2015, GITR+ regulatory T cells in the treatment of autoimmune diseases, Autoimmun Rev, 14, 117, 10.1016/j.autrev.2014.10.011

Liang, 2008, Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II, J Immunol, 180, 5916, 10.4049/jimmunol.180.9.5916

Zhang, 2008, Expression of surface markers on peripheral CD4+CD25high T-cells in patients with atopic asthma: role of inhaled corticosteroid, Chin Med J (Engl), 121, 205, 10.1097/00029330-200802010-00004

Afzali, 2007, The role of T helper 17 (Th17) and regulatory tcells (treg) in human organ transplantation and autoimmune disease, Clin Exp Immunol, 148, 32, 10.1111/j.1365-2249.2007.03356.x

Li, 2009, The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC, Cancer Biother Radiopharm, 24, 357, 10.1089/cbr.2008.0612

Dejaco, 2006, Imbalance of regulatory T cells in human autoimmune diseases, Immunol, 117, 289, 10.1111/j.1365-2567.2005.02317.x

Miyara, 2007, Natural regulatory T cells: mechanisms of suppression, Trends Mol Med, 13, 108, 10.1016/j.molmed.2007.01.003

Toda, 2006, Development and function of naturally occurring CD4+CD25+ regulatory T cells, J Leukoc Biol, 80, 458, 10.1189/jlb.0206095

Caridade, 2013, Mechanisms underlying CD4+ treg immune regulation in the adult: from experiments to models, Front Immunol, 4, 378, 10.3389/fimmu.2013.00378

Lawson, 2006, Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood, Rheumatology (Oxford), 45, 1210, 10.1093/rheumatology/kel089

Liu, 2004, Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus, Scand J Immunol, 59, 198, 10.1111/j.0300-9475.2004.01370.x

Hu, 2008, Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus, J Huazhong Univ Sci Technolog Med Sci, 28, 549, 10.1007/s11596-008-0513-y

Glick, 2013, Impairment of regulatory T-cell function in autoimmune thyroid disease, Thyroid, 23, 871, 10.1089/thy.2012.0514

Feger, 2007, Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients, Clin Exp Immunol, 147, 412, 10.1111/j.1365-2249.2006.03271.x

Frisullo, 2009, Regulatory T cells fail to suppress CD4T+−bet+T cells in relapsing multiple sclerosis patients, Immunology, 127, 418, 10.1111/j.1365-2567.2008.02963.x

Arandi, 2014, Alteration in frequency and function of CD4+CD25+FOXP3+ regulatory T cells in patients with immune thrombocytopenic purpura, Iran J Allergy Asthma Immunol, 13, 85

Dwivedi, 2013, Decreased regulatory T-cells and CD4+/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo, Pigment Cell Melanoma Res, 26, 586, 10.1111/pcmr.12105

Lili, 2012, Global activation of CD8+ cytotoxic T lymphocytes correlates with an impairment in regulatory T cells in patients with generalized vitiligo, PLoS One, 7, 10.1371/journal.pone.0037513

Ben Ahmed, 2012, Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo, Pigment Cell Melanoma Res, 25, 99, 10.1111/j.1755-148X.2011.00920.x

Quaglino, 2013, Flow cytometric analyses of circulating regulatory T cells in patients with dermatitis herpetiformis and other immune mediated dermatoses, G Ital Dermatol Venereol, 148, 197

Grant, 2015, Regulatory T-cells in autoimmune diseases: challenges, controversies and–yet–unanswered questions, Autoimmun Rev, 14, 105, 10.1016/j.autrev.2014.10.012

Buckner, 2010, Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases, Nat Rev Immunol, 10, 849, 10.1038/nri2889

Matsuzaki, 2007, Intestinal microflora: probiotics and autoimmunity, J Nutr, 137, 798S, 10.1093/jn/137.3.798S

Kubota, 2011, Diversity of intestinal bifidobacteria in patients with Japanese cedar pollinosis and possible influence of probiotic intervention, Curr Microbiol, 62, 71, 10.1007/s00284-010-9667-5

Metchnikoff, 1907

Food and Agriculture Organization, 2001, Report of joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria, 10

Vighi, 2008, Allergy and the gastrointestinal system, Clin Exp Immunol, 153, 3, 10.1111/j.1365-2249.2008.03713.x

Rautava, 2002, The development of gut immune responses and gut microbiota: effects of probiotics in prevention and treatment of allergic disease, Curr Issues Intest Microbiol, 3, 15

Heijtz, 2011, Normal gut microbiota modulates brain development and behavior, Proc Natl Acad Sci U S A, 108, 3047, 10.1073/pnas.1010529108

Vijay-Kumar, 2010, Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5, Science, 328, 228, 10.1126/science.1179721

Maslowski, 2009, Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43, Nature, 461, 1282, 10.1038/nature08530

Hooper, 2010, Immune adaptations that maintain homeostasis with the intestinal microbiota, Nat Rev Immunol, 10, 159, 10.1038/nri2710

Topping, 2001, Short chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides, Physiol Rev, 81, 1031, 10.1152/physrev.2001.81.3.1031

Kau, 2011, Human nutrition, the gut microbiome and the immune system, Nature, 474, 327, 10.1038/nature10213

Atarashi, 2011, Induction of colonic regulatory T cells by indigenous Clostridium species, Science, 331, 337, 10.1126/science.1198469

Hill, 2010, Intestinal bacteria and the regulation of immune cell homeostasis, Annu Rev Immunol, 28, 623, 10.1146/annurev-immunol-030409-101330

Macpherson, 2004, Interactions between commensal intestinal bacteria and the immune system, Nat Rev Immunol, 4, 478, 10.1038/nri1373

Uronis, 2009, Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility, PLoS One, 4, 10.1371/journal.pone.0006026

Min, 2015, The role of microbiota on the gut immunology, Clin Ther, 37, 968, 10.1016/j.clinthera.2015.03.009

Wu, 2012, The role of gut microbiota in immune homeostasis and autoimmunity, Gut Microbes, 3, 4, 10.4161/gmic.19320

Schley, 2002, The immune-enhancing effects of dietary fibres and prebiotics, Brit J Nutr, 87, S221, 10.1079/BJN/2002541

Kolida, 2002, Prebiotic effects of inulin and oligofructose, Brit J Nutr, 87, S193, 10.1079/BJN/2002537

Vinolo, 2011, Regulation of inflammation by short chain fatty acids, Nutrients, 3, 858, 10.3390/nu3100858

Park, 2007, Anti-inflammatory effects of short chain fatty acids in IFN-γ-stimulated RAW 264.7 murine macrophage cells: involvement of NF-ƙB and ERK signaling pathways, Int Immunopharmacol, 7, 70, 10.1016/j.intimp.2006.08.015

Chakravortty, 2000, The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells, J Endotoxin Res, 6, 243, 10.1177/09680519000060030501

Menzel, 2004, Butyrate inhibits leukocyte adhesion to endothelial cells via modulation of VCAM-1, Inflamm Bowel Dis, 10, 122, 10.1097/00054725-200403000-00010

Bohmig, 1997, n-Butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: A potential mechanism for modulating T-cell responses by short-chain fatty acids, Immunology, 92, 234, 10.1046/j.1365-2567.1997.00337.x

Huda-Faujan, 2010, The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects, Open Biochem J, 4, 53, 10.2174/1874091X01004010053

Vernia, 1988, Fecal lactate and ulcerative colitis, Gastroenterology, 95, 1564, 10.1016/S0016-5085(88)80078-7

McIntyre, 1993, Butyrate production from dietary fibre and protection against large bowel cancer in a rat model, Gut, 34, 386, 10.1136/gut.34.3.386

Cox, 2009, Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines, World J Gastroenterol, 15, 5549, 10.3748/wjg.15.5549

Wiemer, 2011, A live imaging cell motility screen identifies prostaglandin E2 as a T cell stop signal antagonist, J Immunol, 187, 3663, 10.4049/jimmunol.1100103

Tedelind, 2007, Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease, World J Gastroenterol, 13, 2826, 10.3748/wjg.v13.i20.2826

Vinolo, 2011, Suppressive effect of short chain fatty acids on production of proinflammatory mediators by neutrophils, J Nutr Biochem, 22, 849, 10.1016/j.jnutbio.2010.07.009

Bringiotti, 2014, Intestinal microbiota: the explosive mixture at the origin of inflammatory bowel disease?, World J Gastrointest Pathophysiol, 5, 550, 10.4291/wjgp.v5.i4.550

Moro, 2006, A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age, Arch Dis Child, 91, 814, 10.1136/adc.2006.098251

Bassaganya-Riera, 2011, Soluble fibers and resistant starch ameliorate disease activity in interleukin-10–deficient mice with inflammatory bowel disease, J Nutr, 141, 1318, 10.3945/jn.111.139022

Vulevic, 2008, Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers, Am J Clin Nutr, 88, 1438, 10.3945/ajcn.2008.26242

Smits, 2005, Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin, J Allergy Clin Immunol, 115, 1260, 10.1016/j.jaci.2005.03.036

Konstantinov, 2008, S layer protein a of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions, Proc Natl Acad Sci U S A, 105, 19474, 10.1073/pnas.0810305105

Christensen, 2002, Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells, J Immunol, 168, 171, 10.4049/jimmunol.168.1.171

Di Giacinto, 2005, Probiotics ameliorate recurrent Th-1 mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-β- bearing regulatory cells, J Immunol, 174, 3237, 10.4049/jimmunol.174.6.3237

Niers, 2007, Selection of probiotic bacteria for prevention of allergic diseases: immunomodulation of neonatal dendritic cells, Clin Exp Immunol, 149, 344, 10.1111/j.1365-2249.2007.03421.x

Niers, 2005, Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines, Clin Exp Allergy, 35, 1481, 10.1111/j.1365-2222.2005.02375.x

Hart, 2004, Modulation of human dendritic cell phenotype and function by probiotic bacteria, Gut, 53, 1602, 10.1136/gut.2003.037325

Braat, 2004, Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function, Am J Clin Nutr, 80, 1618, 10.1093/ajcn/80.6.1618

Drakes, 2004, Bacterial probiotic modulation of dendritic cells, Infect Immun, 72, 3299, 10.1128/IAI.72.6.3299-3309.2004

Rigby, 2005, Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli, Clin Exp Immunol, 139, 245, 10.1111/j.1365-2249.2004.02674.x

Kwon, 2010, Generation of regulatory dendritic cells and CD4+FoxP3+ T cells by probiotics administration suppresses immune disorders, Proc Natl Acad Sci U S A, 107, 2159, 10.1073/pnas.0904055107

Yagi, 2004, Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T-cells, Int Immunol, 16, 1643, 10.1093/intimm/dxh165

Joetham, 2007, Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-β, J Immunol, 178, 1433, 10.4049/jimmunol.178.3.1433

Zheng, 2002, Generation ex vivo of TGF-β-producing regulatory T cells from CD4+CD25− precursors, J Immunol, 169, 4183, 10.4049/jimmunol.169.8.4183

Fu, 2004, TGF-β induces FoxP3+ T-regulatory cells from CD4+CD25− precursors, Am J Transplant, 4, 1614, 10.1111/j.1600-6143.2004.00566.x

Fantini, 2004, Cutting edge: TGF-β induces a regulatory phenotype in CD4+CD25− T cells through FoxP3 induction and down-regulation of Smad7, J Immunol, 172, 5149, 10.4049/jimmunol.172.9.5149

Liang, 2005, Conversion of CD4+ CD25− cells into CD4+CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus, J Exp Med, 201, 127, 10.1084/jem.20041201

Chen, 2010, TGF-beta and ‘adaptive’ FoxP3+ regulatory T cells, J Mol Cell Biol, 2, 30, 10.1093/jmcb/mjp004

O'Garra, 2004, IL-10-producing and naturally occurring CD4+ tregs: limiting collateral damage, J Clin Invest, 114, 1372, 10.1172/JCI23215

Gribben, 1995, CTLA4 mediates antigen-specific apoptosis of human T cells, Proc Natl Acad Sci U S A, 92, 811, 10.1073/pnas.92.3.811

Waterhouse, 1995, Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4, Science, 270, 985, 10.1126/science.270.5238.985

Chen, 2006, Modeling CTLA4-linked autoimmunity with RNA interference in mice, Proc Natl Acad Sci U S A, 103, 16400, 10.1073/pnas.0607854103

O'Mahony, 2008, Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-ƙB activation, PLoS Pathog, 4, 10.1371/journal.ppat.1000112

O'Mahony, 2005, Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles, Gastroenterology, 128, 541, 10.1053/j.gastro.2004.11.050

Whorwell, 2006, Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome, Am J Gastroenterol, 101, 1581, 10.1111/j.1572-0241.2006.00734.x

Schwartz, 2005, Natural regulatory T cells and self tolerance, Nat Immunol, 6, 327, 10.1038/ni1184

Issazadeh-Navikas, 2012, Influence of dietary components on regulatory T cells, Mol Med, 18, 95, 10.2119/molmed.2011.00311

Feleszko, 2007, Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma, Clin Exp Allergy, 37, 498, 10.1111/j.1365-2222.2006.02629.x

Kim, 2008, Effect of oral probiotics (Bifidobacterium lactis AD011 and Lactobacillus acidophilus AD031) administration on ovalbumin-induced food allergy mouse model, J Microbiol Biotechnol, 18, 1393

Kim, 2012, Probiotic modulation of dendritic cells co-cultured with intestinal epithelial cells, World J Gastroenterol, 18, 1308, 10.3748/wjg.v18.i12.1308

Lavasani, 2010, A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells, PLoS One, 5, 10.1371/journal.pone.0009009

Kim, 2014, Effects of Lactobacillus rhamnosus on allergic March model by suppressing Th2, Th17, and TSLP responses via CD4(+)CD25(+)FoxP3(+) tregs, Clin Immunol, 153, 178, 10.1016/j.clim.2014.04.008

Atarashi, 2013, Treg induction by a rationally selected mixture of clostridia strains from the human microbiota, Nature, 500, 232, 10.1038/nature12331

Hacini-Rachinel, 2009, Oral probiotic control skin inflammation by acting on both effector and regulatory T cells, PLoS One, 4, 10.1371/journal.pone.0004903

So, 2008, Lactobacillus casei potentiates induction of oral tolerance in experimental arthritis, Mol Immunol, 46, 172, 10.1016/j.molimm.2008.07.038

Karimi, 2009, Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice, Am J Respir Crit Care Med, 179, 186, 10.1164/rccm.200806-951OC

Roselli, 2009, Prevention of TNBS-induced colitis by different lactobacillus and Bifidobacterium strains is associated with an expansion of gamma-deltaT and regulatory T cells of intestinal intraepithelial lymphocytes, Inflamm Bowel Dis, 15, 1526, 10.1002/ibd.20961

Pronio, 2008, Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells, Inflamm Bowel Dis, 14, 662, 10.1002/ibd.20369

Chapat, 2004, Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation, Eur J Immunol, 34, 2520, 10.1002/eji.200425139

Weise, 2011, Oral administration of Escherichia coli nissle 1917 prevents allergen-induced dermatitis in mice, Exp Dermatol, 20, 805, 10.1111/j.1600-0625.2011.01326.x

Meka, 2015, IL-27-induced modulation of autoimmunity and its therapeutic potential, Autoimmun Rev, 14, 1131, 10.1016/j.autrev.2015.08.001

Hall, 2012, The cytokines interleukin 27 and interferon-gamma promote distinct treg cell populations required to limit infection-induced pathology, Immunity, 37, 511, 10.1016/j.immuni.2012.06.014

Yoshida, 2015, The immunobiology of interleukin-27, Annu Rev Immunol, 33, 417, 10.1146/annurev-immunol-032414-112134

Moon, 2013, In vivo action of IL-27: reciprocal regulation of Th17 and treg cells in collagen-induced arthritis, Exp Mol Med, 45, 10.1038/emm.2013.89

Do, 2015, An IL-27/Lag3 axis enhances Foxp3 regulatory T cell-suppressive function and therapeutic efficacy, Mucosal Immunol

Jeon, 2012, Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon, PLoS Pathog, 8, 10.1371/journal.ppat.1002714

Sung, 2012, Regulation of T helper 17 by bacteria: an approach for the treatment of hepatocellular carcinoma, Int J Hepatol, 2012, 439024, 10.1155/2012/439024

Chen, 2009, Effect of probiotics Lactobacillus acidophilus on citrobacter rodentium colitis: the role of dendritic cells, Pediatr Res, 65, 169, 10.1203/PDR.0b013e31818d5a06

Jan, 2012, Lactobacillus gasseri suppresses Th17 pro-inflammatory response and attenuates allergen-induced airway inflammation in a mouse model of allergic asthma, Br J Nutr, 108, 130, 10.1017/S0007114511005265

Veckman, 2004, Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells, J Leukoc Biol, 75, 764, 10.1189/jlb.1003461

López, 2011, Immune response to Bifidobacterium bifidum strains support treg/Th17 plasticity, PLoS One, 6, 10.1371/journal.pone.0024776

Noack, 2014, Th17 and regulatory T cell balance in autoimmune and inflammatory diseases, Autoimmun Rev, 13, 668, 10.1016/j.autrev.2013.12.004

Miettinen, 2000, Lactobacilli and streptococci activate NF-ƙB and STAT signaling pathways in human macrophages, J Immunol, 164, 3733, 10.4049/jimmunol.164.7.3733

Laurence, 2007, Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation, Immunity, 26, 371, 10.1016/j.immuni.2007.02.009

Wheeler, 1997, Impact of dietary yogurt on immune function, Am J Med Sci, 313, 120, 10.1097/00000441-199702000-00011

Mokrozub, 2014, Effect of lactobacilli probiotic strains on IFN-γ, IL-2 and TNF-α- production in the peripheral blood cells culture of clinically healthy donors, EPMA J, 5, A135, 10.1186/1878-5085-5-S1-A135

Perdigon, 2002, Interaction of lactic acid bacteria with the gut immune system, Eur J Clin Nutr, 56, S21, 10.1038/sj.ejcn.1601658

Marschan, 2008, Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation, Clin Exp Allergy, 38, 611, 10.1111/j.1365-2222.2008.02942.x

Gareau, 2010, Probiotics and the gut microbiota in intestinal health and disease, Nat Rev Gastroenterol Hepatol, 7, 503, 10.1038/nrgastro.2010.117

Rachmilewitz, 2004, Toll-like receptor 9 signaling mediates anti-inflammatory effects of probiotics in murine experimental colitis, Gastroenterology, 126, 520, 10.1053/j.gastro.2003.11.019

Hoarau, 2006, Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a toll-like receptor 2 pathway, J Allergy Clin Immunol, 117, 696, 10.1016/j.jaci.2005.10.043

Forsythe, 2007, Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice, Am J Respir Crit Care Med, 175, 561, 10.1164/rccm.200606-821OC

Baban, 2005, Minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type-I IFN signaling following B7 ligation, Int Immunol, 17, 909, 10.1093/intimm/dxh271

Aumeunier, 2010, Systemic toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice, PLoS One, 5, 10.1371/journal.pone.0011484

Round, 2011, The toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota, Science, 332, 974, 10.1126/science.1206095

Mazmanian, 2008, A microbial symbiosis factor prevents intestinal inflammatory disease, Nature, 453, 620, 10.1038/nature07008

Mazmanian, 2005, An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system, Cell, 122, 107, 10.1016/j.cell.2005.05.007

Zeng, 2015, Metabolic control of regulatory T cell development and function, Trends Immunol, 36, 3, 10.1016/j.it.2014.08.003

Goldsmith, 2014, The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications, J Gastroenterol, 49, 785, 10.1007/s00535-014-0953-z

Hamer, 2008, The role of butyrate on colonic function, Aliment Pharmacol Ther, 27, 104, 10.1111/j.1365-2036.2007.03562.x

Frank, 2007, Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases, Proc Natl Acad Sci U S A, 104, 13780, 10.1073/pnas.0706625104

Wang, 2012, Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers, ISME J, 6, 320, 10.1038/ismej.2011.109

Smith, 2013, The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis, Science, 341, 569, 10.1126/science.1241165

Blad, 2012, G protein-coupled receptors for energy metabolites as new therapeutic targets, Nat Rev Drug Discov, 11, 603, 10.1038/nrd3777

Ganapathy, 2013, Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host, Curr Opin Pharmacol, 13, 869, 10.1016/j.coph.2013.08.006

Taggart, 2005, (D)-beta-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G, J Biol Chem, 280, 26649, 10.1074/jbc.C500213200

Thangaraju, 2009, GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon, Cancer Res, 69, 2826, 10.1158/0008-5472.CAN-08-4466

Cresci, 2010, Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8, J Gastrointest Surg, 14, 449, 10.1007/s11605-009-1045-x

Lukasova, 2011, Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells, J Clin Invest, 121, 1163, 10.1172/JCI41651

Hegyi, 2004, Pellagra: dermatitis, dementia, and diarrhea, Int J Dermatol, 43, 1, 10.1111/j.1365-4632.2004.01959.x

Singh, 2014, Activation of GPR109A, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis, Immunity, 40, 128, 10.1016/j.immuni.2013.12.007

Le Poul, 2003, Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation, J Biol Chem, 278, 25481, 10.1074/jbc.M301403200

Kim, 2012, A novel therapeutic target, GPR43; where it stands in drug discovery, Arch Pharm Res, 35, 1505, 10.1007/s12272-012-0900-6

Cousens, 1979, Different accessibilities in chromatin to histone acetylase, J Biol Chem, 254, 1716, 10.1016/S0021-9258(17)37831-6

Glozak, 2005, Acetylation and deacetylation of non-histone proteins, Gene, 363, 15, 10.1016/j.gene.2005.09.010

Li, 2007, FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression, Proc Natl Acad Sci U S A, 104, 4571, 10.1073/pnas.0700298104

Wang, 2009, Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance, Immunol Cell Biol, 87, 195, 10.1038/icb.2008.106

Tao, 2007, Deacetylase inhibition promotes the generation and function of regulatory T cells, Nat Med, 13, 1299, 10.1038/nm1652

Arpaia, 2013, Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation, Nature, 504, 451, 10.1038/nature12726

Furusawa, 2013, Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells, Nature, 504, 446, 10.1038/nature12721

Chang, 2014, The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition, Proc Natl Acad Sci U S A, 111, 2247, 10.1073/pnas.1322269111

Willemsen, 2003, Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts, Gut, 52, 1442, 10.1136/gut.52.10.1442

Nitta, 2002, Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329, Scand J Immunol, 56, 66, 10.1046/j.1365-3083.2002.01096.x

Kalinski, 2012, Regulation of immune responses by prostaglandin E2, J Immunol, 188, 21, 10.4049/jimmunol.1101029

Perez, 1998, Sodium butyrate upregulates kupffer cell PGE2 production and modulates immune function, J Surg Res, 78, 1, 10.1006/jsre.1998.5316

Sharma, 2005, Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer, Cancer Res, 65, 5211, 10.1158/0008-5472.CAN-05-0141

Bergmann, 2007, Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma, Cancer Res, 67, 8865, 10.1158/0008-5472.CAN-07-0767

Soontrapa, 2011, Prostaglandin E2- prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation induced systemic immunosuppression, Proc Natl Acad Sci U S A, 108, 6668, 10.1073/pnas.1018625108

Mahic, 2006, FOXP3+ CD4+ CD25+ adaptive regulatory T cells express cyclooxygenase-2 and suppress effector T cells by a prostaglandin E2-dependent mechanism, J Immunol, 177, 246, 10.4049/jimmunol.177.1.246

Phipps, 1991, A new view of prostaglandin E regulation of the immune response, Immunol Today, 12, 349, 10.1016/0167-5699(91)90064-Z

Muthuswamy, 2008, Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation, Cancer Res, 68, 5972, 10.1158/0008-5472.CAN-07-6818

Baratelli, 2005, Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells, J Immunol, 175, 1483, 10.4049/jimmunol.175.3.1483

Whiteside, 2013, Adenosine and prostaglandin E2 production by human inducible regulatoryT cells in health and disease, Front Immunol, 4, 212, 10.3389/fimmu.2013.00212

Su, 2008, Cooperation of adenosine and prostaglandin E2 (PGE2) in amplification of cAMP-PKA signaling and immunosuppression, Cancer Immunol Immunother, 57, 1611, 10.1007/s00262-008-0494-5

Round, 2010, Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota, Proc Natl Acad Sci U S A, 107, 12204, 10.1073/pnas.0909122107

Ochoa-Repáraz, 2009, Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis, J Immunol, 183, 6041, 10.4049/jimmunol.0900747

Ochoa-Repáraz, 2010, A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease, Mucosal Immunol, 3, 487, 10.1038/mi.2010.29

Prioult, 2003, Effect of probiotic bacteria on induction and maintenance of oral tolerance to β-lactoglobulin in gnotobiotic mice, Clin Diagn Lab Immunol, 10, 787, 10.1128/CDLI.10.5.787-792.2003

Prioult, 2004, Stimulation of interleukin-10 production by acidic beta lactoglobulin-derived peptides hydrolyzed with lactobacillus paracasei NCC2461 peptidases, Clin Diagn Lab Immunol, 11, 266, 10.1128/CDLI.11.2.266-271.2004